COMBI — Combigene AB Income Statement
0.000.00%
Last trade - 00:00
- SEK76.23m
- -SEK25.21m
- SEK5.54m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | SAS | — | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 84 | 26.7 | 5.54 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17.7 | 28.2 | 63.1 | 33.6 | 44.1 |
Operating Profit | -17.7 | -28.2 | 21 | -6.95 | -38.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.9 | -29.6 | 21 | -6.16 | -35.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.9 | -29.6 | 21 | -6.16 | -35.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -17.6 | -29.4 | 21 | -6.16 | -35.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.6 | -29.4 | 21 | -6.16 | -35.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.54 | -3.18 | 1.34 | -0.195 | -1.8 |
Dividends per Share |